Literature DB >> 24433452

Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias.

Sebastian Tschernitz1, Lucia Flossbach, Margrit Bonengel, Sabine Roth, Andreas Rosenwald, Eva Geissinger.   

Abstract

The BRAF V600E mutation in exon 15 is considered the disease-defining mutation in hairy cell leukaemia (HCL), but single HCL cases lacking this mutation have been described. In 24 HCL, as well as in 194 various mature B- and T-cell neoplasms, we extended the search for BRAF mutations to exon 11. Two V600E-negative HCL contained novel, potentially functionally relevant mutations in exon 11 (F468C and D449E), while one other HCL was BRAF wild-type in exons 2-17. All non-HCL lymphomas lacked BRAF mutations. We therefore suggest screening of BRAF V600E-negative HCL for alternative exon 11 mutations in the diagnostic setting.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  BRAF; alternative mutations; diagnostics; exon 11; hairy cell leukaemia

Mesh:

Substances:

Year:  2014        PMID: 24433452     DOI: 10.1111/bjh.12735

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

Review 1.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

2.  Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.

Authors:  Xuan J Wang; Annette Kim; Shaoying Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Exceptions to the rule in hairy cell leukaemia: implications for molecular diagnostics and targeted therapy.

Authors:  Stephen E Langabeer
Journal:  Med Oncol       Date:  2014-02-21       Impact factor: 3.064

4.  BRAF in the cross-hairs.

Authors:  Mark B Geyer; Omar Abdel-Wahab; Martin S Tallman
Journal:  Expert Rev Hematol       Date:  2019-02-26       Impact factor: 2.929

Review 5.  Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.

Authors:  Jérôme Paillassa; Elsa Maitre; Xavier Troussard
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

Review 6.  Hairy cell leukemia: Past, present and future.

Authors:  Bartlomiej M Getta; Jae H Park; Martin S Tallman
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-21       Impact factor: 3.020

Review 7.  MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

Authors:  Rikhia Chakraborty; Omar Abdel-Wahab; Benjamin H Durham
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915

8.  Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Authors:  Alessandro Broccoli; Carolina Terragna; Laura Nanni; Marina Martello; Silvia Armuzzi; Claudio Agostinelli; Alice Morigi; Beatrice Casadei; Cinzia Pellegrini; Vittorio Stefoni; Elena Sabattini; Lisa Argnani; Pier Luigi Zinzani
Journal:  Hematol Oncol       Date:  2021-10-15       Impact factor: 4.850

Review 9.  BRAF Mutation in Hairy Cell Leukemia.

Authors:  Ahmad Ahmadzadeh; Saeid Shahrabi; Kaveh Jaseb; Fatemeh Norozi; Mohammad Shahjahani; Tina Vosoughi; Saeideh Hajizamani; Najmaldin Saki
Journal:  Oncol Rev       Date:  2014-09-23

10.  Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Am J Hematol       Date:  2017-12       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.